Episode 314: October 2021 Retinal Physician Including Discussion of Diabetic Retinopathy, Trials, Focal Laser, and Crunch Effect of Anti-VEGF

Relevant Financial Disclosures: Dr. Sridhar is a consultant for Genentech, Regeneron, Allergan, Alcon, and Dorc. Dr. Thomas is a consultant for Allergan, Avesis, Novartis, and Zeiss. Dr. Vakharia is a consultant for Genentech and have honoraria for Bausch and Lomb.

Om Podcasten

An informal yet insightful commentary featuring interviews and perspectives from leaders in vitreoretinal surgery as well as the next generation of retinal specialists